Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Healthcare Copper
Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Medivolve Inc > Pharmacy services is JUST NOT PROFITABLE per NHS
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1060)
•••
Post by Hiddensecretson Mar 17, 2021 3:59pm
96 Views
Post# 32818788

Pharmacy services is JUST NOT PROFITABLE per NHS

Pharmacy services is JUST NOT PROFITABLE per NHS

Pharmacy services ‘just not profitable’, NHS conference hears

Providing services is “just not profitable” for pharmacies, Mr Burnell said at the NHS Confederation conference in Manchester last week (June 19). He claimed that “some of the bigger multiples” in his area had stopped offering some enhanced services, causing workload to filter onto other healthcare providers.

While community pharmacies know the value of providing healthcare services, ongoing “austerity measures” mean they are “under so much pressure to just make ends meet” that they could be forced to say: “I understand the value of this, but I can’t do it.”

“I think we’re in danger of losing some of that [pharmacy] network,” he added.

https://www.chemistanddruggist.co.uk/news/community-pharmacy-services-not-profitable

mpo

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities